CRISPR Therapeutics (CRSP) Sees IPO Price of $15 - $17/Share

October 7, 2016 10:54 AM EDT
Get Alerts CRSP Hot Sheet
Trade CRSP Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

CRISPR Therapeutics AG (Nasdaq: CRSP) filed an amended registration with the U.S. SEC for an initial public offering of its common stock. The company plans to sell 4.7 million shares and sees an offering price of $15 to $17 per share.

The offering is being made through Citigroup, Piper Jaffray, Barclays, and Guggenheim Securities.

CRISPR Therapeutics is a leading gene editing company focused on the development of CRISPR/Cas9-based therapeutics.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Piper Jaffray, Citi, Barclays, IPO, Guggenheim

Add Your Comment